Skip to main content

Table 3 Proportion of patients who restarted systemic treatment after IAS injection

From: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry

 

6 months*

12 months**

Prior biologic use

0.68 (15/22)

0.85 (17/20)

No biologic

0.24 (4/17)

0.40 (4/10)

Total

0.49 (19/39)

0.7 (21/30)

  1. *p < 0.01, ** p < 0.05
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096